10-K Decoder · All companies

Atea Pharmaceuticals, Inc.

AVIR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$181M−$193M+6.3%
Net income−$158M−$168M+6.0%

Questions

What was Atea Pharmaceuticals's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Atea Pharmaceuticals profitable in FY2025?
No: net income was −$158M and operating income −$181M in FY2025.